These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6640637)
1. [Preparation of a live Shigella vaccine using T32 strain (Roumania) in a form of popsicle and observation of its prophylactic efficacy]. Zhao B Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):230-2. PubMed ID: 6640637 [No Abstract] [Full Text] [Related]
2. Immunoprophylaxis against bacillary dysentery by dysentery live vaccine Vadizen (Shigella flexneri T32-Istrati) in children collectivities in SV County. Bogus L; Ianopol L; Dascălu C; Bende B; Iliescu C; Carliuc V; Meitert T; Pencu E; Ciudin L; Tonciu M Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):291-8. PubMed ID: 6400302 [No Abstract] [Full Text] [Related]
3. Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati). Meitert T; Pencu E; Ciudin L; Tonciu M Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):251-78. PubMed ID: 6400299 [No Abstract] [Full Text] [Related]
4. Reduction of morbidity due to bacillary dysentery by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in BH County. Pop C; Cernea L; Ciortea A; Ianossy L; Kallay T; Lugoş A; Meitert T; Ciudin L; Pencu E Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):351-6. PubMed ID: 6400310 [No Abstract] [Full Text] [Related]
5. Immunoprophylactic effect of dysentery vaccination by live dysentery vaccine Vadizen (Sh. flexneri T32-Istrati) in children and adult collectivities in BT County. Cîmpeanu S; Harasim T; Popovici S; Popa T; Meitert T; Pencu E; Ciudin L; Tonciu M Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):305-12. PubMed ID: 6400304 [No Abstract] [Full Text] [Related]
6. Results of dysentery vaccinations by live vaccine Vadizen (Sh. flexneri 2a T32-Istrati) in children collectivities in GL. Brebenel G; Barabas E; Delcea D; Meitert T; Pencu E; Ciudin L Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):299-304. PubMed ID: 6400303 [No Abstract] [Full Text] [Related]
7. Antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in PH County. Cuteanu I; Malamen G; Vlad A; Meitert T; Ciudin L; Pencu E; Tonciu M Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):313-21. PubMed ID: 6400305 [No Abstract] [Full Text] [Related]
8. Prophylaxis of bacillary dysentery by liver vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in IS County. Oană C; Buzdugan T; Constantiniu S; Cismaru M; Alexandru D; Dunea C; Funiac A; Radu M; Grumăzescu C; Meitert T Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):331-5. PubMed ID: 6400307 [No Abstract] [Full Text] [Related]
9. Study on the effect of oral immunization of T32-Istrati strain against bacillary dysentery in field trials. Bingrui W Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):285-9. PubMed ID: 6400301 [No Abstract] [Full Text] [Related]
10. Investigations concerning the immunoprophylactic effect of the antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children. Dragomir I; Iancu V; Călţun M; Raicu M; Meitert T; Pencu E; Ciudin L Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):323-9. PubMed ID: 6400306 [No Abstract] [Full Text] [Related]
11. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals. Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598 [No Abstract] [Full Text] [Related]
13. Efficiency of immunoprophylaxis and immunotherapy by live dysentery vaccine administration in children and adults collectivities. Meitert T; Ciudin L; Pencu E; Tonciu M; Gheorghe G Arch Roum Pathol Exp Microbiol; 1982; 41(4):357-69. PubMed ID: 6763515 [No Abstract] [Full Text] [Related]
14. Development and administration of live Shigella vaccines. Pencu E Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):231-50. PubMed ID: 6443689 [No Abstract] [Full Text] [Related]
15. Vaccine research and development. New strategies for accelerating Shigella vaccine development. Wkly Epidemiol Rec; 1997 Mar; 72(11):73-9. PubMed ID: 9115858 [No Abstract] [Full Text] [Related]
16. [Preliminary studies on preparation of dysenteric vaccines with a bacillary polysaccharide-protein complex and its use in human immunization]. Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Oct; 3(5):281-5. PubMed ID: 7185470 [No Abstract] [Full Text] [Related]
17. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain. Ranallo RT; Thakkar S; Chen Q; Venkatesan MM Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494 [TBL] [Abstract][Full Text] [Related]
18. A review of the current status of enteric vaccines. Levine MM; Noriega F P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876 [TBL] [Abstract][Full Text] [Related]
19. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors. Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732 [No Abstract] [Full Text] [Related]
20. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children. Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]